Trump administration probe could upend widely used transgender youth treatment guidelines
The organization widely regarded as the leading authority on transgender medical treatment is facing allegations from the Federal Trade Commission that it built influential treatment guidelines for minors on evidence its own leaders privately acknowledged was limited and uncertain.























